Oral contraception in adolescents with type 1 diabetes and its association with cardiovascular risk factors. A multicenter DPV study on 24 011 patients from Germany, Austria or Luxembourg.
Barbara BohnKirsten MönkemöllerDörte HilgardAxel DostKarl Otfried SchwabEggert LilienthalElke HammerKathrin HakeMaria FritschBettina GohlkeCarine de BeaufortReinhard W Hollnull nullPublished in: Pediatric diabetes (2018)
OC use in adolescent girls with type 1 diabetes was associated with a poorer cardiovascular risk profile. Biological risk factors were partly explained by a clustering of sociodemographic and lifestyle factors with a small additional contribution of OC use. Prescription of OC should therefore be combined with a screening for cardiovascular risk factors and targeted education.
Keyphrases
- cardiovascular risk factors
- metabolic syndrome
- cardiovascular disease
- risk factors
- end stage renal disease
- physical activity
- ejection fraction
- newly diagnosed
- young adults
- chronic kidney disease
- healthcare
- prognostic factors
- quality improvement
- weight loss
- type diabetes
- cross sectional
- clinical trial
- cancer therapy
- single cell
- patient reported